Previous studies have shown the importance of biomarkers for NSCLC, such as EPCAM, HIF1A, PKM, PTK7, ALCAM, CADM1, and SLC2A1, which were used as a single biomarker for predicting prognostic condition or metastasis5–11. Here, PKM is linked to non-small cell lung carcinoma.